PEL

Nicholas Piramal India Ltd. has informed the Exchange that by an Order made on October 19, 2007, in the Company Application, the Hon'ble High Court of Judicature at Bombay has directed that a meeting of the Equity Shareholders of the Applicant Company (Nicholas Piramal India Ltd.), be convened and held on November 23, 2007 for the purpose of considering and if thought fit, approving, with or without modifications, the arrangements embodied in the Composite Scheme of Arrangement ("the Scheme") between Nicholas Piramal India Limited and NPIL Research and Development Limited. A copy of the Notice

Nicholas Piramal India Ltd. has informed the Exchange vide its letter dated October 25, 2007 that : " Mr. N. Santhanam - Group President (Finance & Legal) and Chief Financial Officer, has today been inducted as an Executive Director on the Board of the Company".

Nicholas Piramal India Ltd. has informed the Exchange regarding a press release dated October 25, 2007, titled "Nicholas Piramal reports Q2 FY2008 results; Total Revenues grow 17% to Rs.7.6 billion, Net Profit up by 58% to Rs.847.4 million". The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Nicholas_PR_25102007.zip target=NEW> For more details click here.</a>

Nicholas Piramal India Ltd. has informed the Exchange regarding the consolidated Results for the quarter ended on 30-SEP-2007 as follows: Net Sales of Rs. 76457 lacs for quarter ending on 30-SEP-2007 against Rs. 65466 lacs for the quarter ending on 30-SEP-2006. Net Profit / (Loss) of Rs. 8477 lacs for the quarter ending on 30-SEP-2007 against Rs. 5369 lacs for the quarter ending on 30-SEP-2006.

Nicholas Piramal India Ltd. has informed the Exchange regarding the standalone Results for the half year ended on 30-SEP-2007 as follows: Net Sales of Rs. 92684 lacs for half year ending on 30-SEP-2007 against Rs. 84331 lacs for the half year ending on 30-SEP-2006. Net Profit / (Loss) of Rs. 11537 lacs for the half year ending on 30-SEP-2007 against Rs. 11806 lacs for the half year ending on 30-SEP-2006.

Nicholas Piramal India Ltd. has informed the Exchange vide their letter dated October 05, 2007, that: "The duly authorised Committee of Directors have today approved the merger of the Company's wholly-owned subsidiary, NPIL Healthcare Pvt. Ltd. with the Company".

Nicholas Piramal India Ltd. has informed the Exchange vide its letter dated September 04, 2007 that "Mr. Michael J. Fernandes-Executive Director (CMG) has resigned from the services of the Company for personal reasons".

Nicholas Piramal India Ltd. has informed the Exchange vide its letter dated August 31, 2007, that: "The Board of Directors at its Meeting held today, approved the proposal of de-merging its New Chemical Entity (NCE) Research Unit under a Scheme of Arrangement into a separate company (Transferee Company) in which Nicholas Piramal India Limited (NPIL) will hold equity capital of Rs.5 crores. Under the proposed Demerger Scheme, the NCE Undertaking with net assets (at book value) inclusive of unutilized monies collected under the Rights Issue of 2005 and intended for R&D to the extent of Rs. 95 cr

Nicholas Piramal India Ltd. has informed the Exchange on July 25, 2007 that "The Board has also today approved a proposal for merger of the Company's wholly owned subsidiary, Nicholas Piramal Consumer Products Pvt. Ltd.(formerly known as Boots Piramal Healthcare Pvt. Ltd.) with the Company".

Nicholas Piramal India Ltd. has informed the Exchange regarding a press release dated July 25, 2007, titled "Nicholas Piramal reports Q1 FY2008 results; Total Revenues increased 16.4% to Rs.6.1 billion, Net Profit was lower by 19.4% to Rs.434.3 million". The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/NicholasPiramal.zip target=NEW> For more details click here.</a>

Nicholas Piramal India Ltd. has informed the Exchange regarding the consolidated Results for the quarter ended on 30-JUN-2007 as follows: Net Sales of Rs. 60807 lacs for quarter ending on 30-JUN-2007 against Rs. 52257 lacs for the quarter ending on 30-JUN-2006. Net Profit / (Loss) of Rs. 4373 lacs for the quarter ending on 30-JUN-2007 against Rs. 5386 lacs for the quarter ending on 30-JUN-2006.

Nicholas Piramal India Ltd. has informed the Exchange regarding the standalone Results for the quarter ended on 30-JUN-2007 as follows: Net Sales of Rs. 39502 lacs for quarter ending on 30-JUN-2007 against Rs. 40152 lacs for the quarter ending on 30-JUN-2006. Net Profit / (Loss) of Rs. 3439 lacs for the quarter ending on 30-JUN-2007 against Rs. 5100 lacs for the quarter ending on 30-JUN-2006.

Nicholas Piramal India Ltd. has informed the Exchange regarding a press release dated July 23, 2007, titled "Nicholas Piramal India Limited's IND-P276- a new drug discovery from Mumbai, India has been approved by USFDA". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Nicholas_PR_23072007.zip target=NEW> For more details click here.</a>

Nicholas Piramal India Ltd. has informed the Exchange that at the AGM of the Company held on June 14, 2007, all the businesses mentioned in the Notice convening the said meeting were transacted and all the resolutions were passed unanimously. A brief summary of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/NicholasPiramalIndia_AGMOutcome.zip target=NEW> For more details click here.</a>

Nicholas Piramal India Ltd. has submitted to the Exchange a copy of the Notice of Annual General Meeting of the Company scheduled to be held on June 14, 2007. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/nicholas_agm_130607.zip target=NEW> For more details click here.</a>

Nicholas Piramal India Ltd. has informed the Exchange that the Board Meeting held today (i.e. April 26, 2007) the Board has declared final Equity Dividend at 25% (i.e. Rs.0.50 per share) on 20,90,17,606 equity shares of Rs.2/- each. This is in addition to the interim Equity dividend at 150% (i.e. Rs.3 per equity share of Rs.2/ each) which was declared by the Board on March 15, 2007. Thus, total Equity Dividend for the financial year ended March 31, 2007 works out to 175% (i.e. Rs.3.50 per share). As regards dividend on Preference Shares, the entire preference dividend was declared and paid as

Nicholas Piramal India Ltd. has informed the Exchange regarding a press release, dated April 26, 2007, titled "Nicholas Piramal reports Q4 FY2007 results; Consolidated Revenues up 51.7% to Rs. 6.4 billion, Operating Profit up 137.9% to Rs. 848.9 million, Net Profit up 262.2% to Rs 549.5 million." A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Nicholas_PR.zip target=NEW> For more details click here.</a>

Nicholas Piramal India Ltd. has informed the Exchange on March 15, 2007 that: "The Board has today declared Interim Equity Dividend @ 150% (i.e. Rs.3 per share) on 20,90,17,606 Equity Shares of Rs.2 each. The Board has also declared interim Dividend on the following Preference Shares: a) @ 5% on 15,00,000 - 5% Cumulative Redeemable Preference Shares of Rs.100/- each; b) @ 5% on 2,33,72,280 - 5% Cumulative Redeemable Preference Shares of Rs.10/- each. The above Interim Dividends would be paid to those members whose names appear on the Company's Register of Members (in case of shares held in phy

Nicholas Piramal India Ltd. has submitted to the Exchange a copy of the Results on Voting by Postal Ballot. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/nicholas_PBres_140307.zip target=NEW> For more details click here.</a>

Nicholas Piramal India Ltd. has informed the Exchange regarding a press release that was issued by the Custom Manufacturing Business Division [NPIL Pharma] at the Informex USA Specialities / Pharma Services Trade Show in San Francisco, USA last night. The Press Release provides details regarding certain development in formulation capabilities and growth plans of NPIL Pharma. The press release dated February 14, 2007, titled "Formulation capabilities to leverage NPIL Pharma growth" shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on

Nicholas Piramal India Ltd. has informed the Exchange that pursuant to Section 192A of the Companies Act, 1956 ('the Act') read with the Companies (Passing of the Resolution by Postal Ballot) Rules 2001, the following resolutions seeking shareholders consent are proposed to be passed as Special Resolutions, by way of Postal Ballot: 1) Special Resolution for re-appointment of and payment of remuneration to Mr. Ajay G. Piramal, as Chairman of the Company, for a further period of 5 years with effect from April 01,2007. 2) Special Resolution seeking consent to the Employees Stock Ownership Plan 20

Nicholas Piramal India Ltd. has informed the Exchange that: "The Company is seeking shareholders approval, through Postal Ballot, for the following proposals: a) For re-appointment of and payment of remuneration to Mr. Ajay G. Piramal, Chairman of the Company, for a further period of 5 years w.e.f. 1st April, 2007; b) For introducing and implementing a new ESOP Scheme called Employee Stock Ownership Plan 2006 and for granting Stock Options to employees / directors of the Company and its subsidiaries under this Scheme; c) For variation in the terms of Stock Options that were granted to employee

Nicholas Piramal India Ltd. has informed the Exchange regarding a press release, dated January 22, 2007, titled "Napo Enters Plant Screening Agreement with Nicholas Piramal India Limited for Diabetes ." The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/NicholasPir_PR_22012007.zip target=NEW> For more details click here.</a>

Nicholas Piramal India Ltd. has informed the Exchange regarding a press release dated January 18,2007, titled "Nicholas Piramal reports Q3 FY 2007 results; Consolidated Revenues up by 60.1% to Rs. 6.5 billion, Operating Profit up by 185.3% to Rs. 970.4 million, Net Profit up by 473.9% to Rs. 555.5 million". The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/NicholasPir_PR_18012007.zip target=NEW> For more details click

Nicholas Piramal India Ltd. has informed the Exchange regarding a press release dated January 12, 2007 titled "Nicholas Piramal announces Drug Development Agreement with Eli and Company - Collaboration Represents a New Clinical Development Model". The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Nichopir_PR_12012007.zip target=NEW> For more details click here.</a>

Nicholas Piramal India Ltd. has informed the Exchange that "Wellspring, the chain of Pathology Laboratories and Diagnostic Centres promoted by Nicholas Piramal India Ltd (NPIL), has acquired Jankharia Imaging, the most successful radiology and imaging centre in Mumbai. The new entity would be renamed as Wellspring Jankharia Imaging. The acquisition has been done by NPIL's wholly-owned subsidiary NPIL Laboratories & Diagnostics Pvt. Ltd. The Company also submitted a copy of press release dated January 04, 2007, titled �Nicholas Piramal's Wellspring acquires majority stake in Jankharia Imaging t

Nicholas Piramal India Ltd. has informed the Exchange that in response to the company's application to the Ahmedabad Stock Exchange Limited for voluntary delisting of securities, the company has been informed by their letter dated November 02,2006 (received by the company on November 15,2006), that the securities of the company have been delisted w.e.f. November 06,2006.

Nicholas Piramal India Ltd. has informed the Exchange regarding a press release dated November 17,2006, titled "BioSyntech signs scientific collaboration agreement with Nicholas Piramal". The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/NicholasP_PR_17112006.zip target=NEW> For more details click here.</a>

Nicholas Piramal India Ltd. has informed the Exchange regarding a press release dated October 27,2006, titled "Nicholas Piramal signs two Platform Technology agreements with Morvus Technology Limited, UK, for R&D programs in Diabetes, Rheumatoid Arthritis and Oncology". The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/NicholasPir_PR_27102006.zip target=NEW> For more details click here.</a>

Nicholas Piramal India Ltd. has informed the Exchange regarding a press release dated October 16,2006, titled "Nicholas Piramal reports Q2 FY2007 results; Consolidated Revenues up by 79.3% to Rs.6.5 billion, Operating Profit up by 76.7% to Rs.1.1 billion, Net Profit up by 17.7% to Rs.536.9 million". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Nicholas_181006.zip target=NEW> For more details click here.</a>

Nicholas Piramal India Ltd. has informed the Exchange regarding a press release dated September 29, 2006, titled "Nicholas Piramal announces acquisition of balance 51% equity stake in Boots Piramal Healthcare Private Limited", being issued by the Company. The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Nicholas_PR_03102006.zip target=NEW> For more details click here.</a>

Nicholas Piramal India Ltd. has informed the Exchange regarding a press release dated August 30,2006, titled "Nicholas Piramal's Wellspring acquires 100 pc stake in Dr Phadke's path labs". The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).

Nicholas Piramal India Ltd. has informed the Exchange that at the AGM of the Company held on June 28,2006, all the businesses mentioned in the Notice convening the said meeting were transacted and all the resolutions were passed unanimously/with overwhelming requisite majority. A brief summary of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).

Nicholas Piramal India Ltd. has informed the Exchange that the following changes have been made to the Board of the company: 1) Mr. G.P. Goenka who has been on the Board of the company (NPIL) since 1986 has submitted his resignation as a Member of the Board due to his other pre-occupations which prevent him from attending all the Board Meetings of the company regularly. 2) Mrs. Urvi A. Piramal also desired to step down from the Board of NPIL. Mrs. Piramal has been on the Board of the company since 1988. 3) Mr. Harsh A. Piramal who was a Non-Working Director of NPIL since June 2004 has submitte

Nicholas Piramal India Ltd. has informed the Exchange that the acquisition of Pfizer's Morpeth UK Facility has been completed on June 19, 2006 as scheduled. As mentioned earlier, the acquisition has been effected by NPIL through its wholly owned subsidiary in the UK viz. NPIL Pharmaceuticals (UK) Limited. (earlier, Avecia Pharmaceuticals, UK).

Nicholas Piramal India Ltd. has informed the Exchange regarding a Press Release being issued by the Company in connection with the acquisition of the manufacturing facility of Pfizer Inc. located at Morpeth, Northumberland, UK. The site is one of Pfizer's global, high quality, integrated facilities and has end-to end production and supply chain capabilities that cover Active Pharmaceutical Ingredients (API), finished dosage, packaging and distribution. The transaction includes a supply agreement up till November 2011, totaling potential revenues exceeding US $ 350 million. This acquisition is

Nicholas Piramal India Ltd. had informed the Exchange regarding the decision of the BoDs, for raising of resources through issue of appropriate securities in domestic and/or international markets, upto an amount not exceeding US$ 1.5 billion, to fund potential acquisitions and to seek shareholders approval through postal ballot for this purpose and matters consequential thereto. The Company has now informed the exchange regarding the Results of the Voting by Postal Ballot. All resolutions have been passed by the shareholders with requisite majority. The details of the results of postal ballo

Nicholas Piramal India Ltd. has informed the Exchange regarding a press release dated May 16,2006, titled "Nicholas Piramal India Limited contemplating acquisitions". The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).

Nicholas Piramal India Ltd. has informed the Exchange that pursuant to Section 192A of the Companies Act, 1956, read with the Companies (passing of the resolution by postal ballot) Rules, 2001, that the following resolutions seeking shareholders consent for raising funds by issue of appropriate securities, for raising the existing borrowing limit of the Company, creating mortgages, etc and to make loans and/or give any guarantee(s) and/or provide any security in connection with loan(s) made to and/or to acquire by way of subscription, share/securities of such body or bodies corporate that may

Nicholas Piramal India Ltd. has informed the Exchange that at the Board meeting held on April 25, 2006, the board has recommended the following dividends : (1) Dividends on preference shares (a) @6% on 15,00,000-6% Non Cumulative Redeemable Preference Shares of Rs.100/- each (b) @5% on 15,00,000-5% cumulative Redeemable Preference Shares of Rs.100/- each (c) @5% on 2,33,72,280-5% Cumulative Redeemable Preference Shares of Rs.10/- each. (2) Dividend on Equity Shares - The Board has recommended dividend of Rs.3 per equity share of Rs.2/- each (150%) for the financial year ended March 31, 2006.

Nicholas Piramal India Ltd. has informed the Exchange that the Board at its meeting held on April 25, 2006 has fixed the date for the AGM of the Company on June 28, 2006. Further, the register of members and share transfer books shall remain closed from June 19, 2006 to June 28, 2006 (both days inclusive), for the purpose of declaration of dividend. The Board has also approved a proposal for de-listing the shares of the Company from the Ahmedabad Stock Exchange, for which shareholders approval would be sought at the ensuing AGM.

Nicholas Piramal India Ltd. has informed the Exchange that the Company has received information from Mr. A. K. Bhat, Officer of the Company regarding sale of 2000 equity shares. The shareholding of Mr. A. K. Bhatt after the sale is 14,500 shares agregating to 0.006% share capital of the company.

Nicholas Piramal India Ltd. has informed the Exchange that Mr. Michael J. Fernandes (Executive Director - Custom Manufacturing Group) has been appointed on January 19, 2006 as a whole time Director on the Board of the Company. Mr. Fernandes recently joined Company on December 01, 2005 and is responsible for the Custom Manufacturing activities of NPIL.

Nicholas Piramal India Ltd. has informed the Exchange that Mr. Vijay Shah, Director of the Company has acquired 1,53,000 shares of Nicholas Piramal India Limited on January 12, 2006. The mode of acquisition is through ESOP and the shareholding of Mr. Vijay Shah after the said acquisition is 2,69,169 shares aggregating to 0.128% of the share capital of Nicholas Piramal India Limited.

Nicholas Piramal India Ltd. has informed the Exchange that Mr. A. K. Bhat, Officer of the Company has acquired 9000 shares of Nicholas Piramal India Limited on January 12, 2006. The mode of acquisition is through ESOP and the shareholding of Mr. A. K. Bhat after the said acquisition is 16,500 shares aggregating to 0.007% of the share capital of the Nicholas Piramal India Limited.

Nicholas Piramal India Ltd. has informed the Exchange that Mr. J.C. Saigal, Officer of the Company has sold 25278 shares of Nicholas Piramal India Limited on January 04, 2006 and January 06, 2006. The mode of sale is through Market and the shareholding of Mr. J.C. Saigal after the said sale is 28252 shares aggregating to 0.014% of the share capital of Nicholas Piramal India Limited.

Nicholas Piramal India Ltd. has informed the Exchange that Mr. A. K. Bhat, Officer of the Company has sold 500 shares of Nicholas Piramal India Limited on January 10, 2006. The mode of sale is through Market and the shareholding of Mr. A. K. Bhat after the said sale is 7,500 shares of Nicholas Piramal India Limited.

Nicholas Piramal India Ltd. has informed the Exchange that Mr. Vijay Shah, Director of the Company has sold 70,228 shares of Nicholas Piramal India Ltd. on January 05, 2006 and January 06, 2006. The mode of sale is through Market and the shareholding of Mr. Vijay Shah after the said sale is 1,16,169 shares aggregating to 0.055% of the share capital of Nicholas Piramal India Ltd..

Nicholas Piramal India Ltd. has informed the Exchange that Mr. Vijay Shah, Director of the Company has sold 45,000 shares of Nicholas Piramal India Ltd. on January 03, 2006 and January 04, 2006. The mode of sale is through Market and the shareholding of Mr. Vijay Shah after the said sale is 1,86,397 shares aggregating to 0.089% of Nicholas Piramal India Ltd.

Nicholas Piramal India Ltd. has informed the Exchange regarding a press release being issued by the Company in connection with the signing of a long term Contract manufacturing related R & D Services Agreement with Pfizer International LLC as follows: "Nicholas Piramal India Limited, India today announced the signing of a long-term contract manufacturing related R&D Services Agreement with Pfizer International LLC. The agreement is for a period of seven years, and is renewable thereafter. Under this agreement, NPIL will provide Process Development and Scale-up services to Pfizer's Animal Hea